{
    "Trade/Device Name(s)": [
        "chromID\u00ae Strepto B agar"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K163042",
    "Predicate Device Reference 510(k) Number(s)": [
        "K881577"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "PQZ"
    ],
    "Summary Letter Date": "January 27, 2017",
    "Summary Letter Received Date": "October 31, 2016",
    "Submission Date": "October 28, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.2360"
    ],
    "Regulation Name(s)": [
        "Selective culture medium"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Group B Streptococcus (Streptococcus agalactiae)"
    ],
    "Specimen Type(s)": [
        "Vaginal/rectal swab (enriched in LIM broth)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Manual culture",
        "Chromogenic medium"
    ],
    "Methodologies": [
        "Culture-based detection"
    ],
    "Submission Type(s)": [
        "Medium"
    ],
    "Document Summary": "FDA 510(k) summary for chromID Strepto B agar selective chromogenic medium for qualitative determination of Group B Streptococcus colonization in pregnant women.",
    "Indications for Use Summary": "Aids in the qualitative determination of Group B Streptococcus (GBS) colonization in pregnant women using vaginal/rectal swabs enriched in LIM broth; not intended for diagnosis or guiding treatment.",
    "fda_folder": "Microbiology"
}